ROARABLE // PRO
GLOBAL DESKS // NYC --:--:-- NYSE
US TAPE
ROAR ▸
COMP <GO>

CSTL vs ALHC // EV/EBITDA & P/E VALUATION

Castle Biosciences Inc. (NASDAQ) VS. Alignment Healthcare Inc. (NASDAQ) • 15-METRIC TALLY: CSTL 2 — ALHC 6
■ METRIC PARITY
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CSTL VS. ALHC) EMERALD CELL = QUANTITATIVE EDGE
INSTITUTIONAL METRIC CSTL ALHC SPREAD (A - B) ADVANTAGE DEDICATED URL
Gross Profit Margin 79.40% — — TIE /gross-margins <GO>
Return on Invested Capital (ROIC) -9.30% 13.90% -23.20 ALHC /roic <GO>
EV/EBITDA & P/E Valuation ACTIVE — 37.8x — TIE /valuation <GO>
Free Cash Flow Yield 2.41% 6.77% -4.36 ALHC /fcf-yield <GO>
Operating Margin -12.40% 0.40% -12.80 ALHC /operating-margins <GO>
Net Profit Margin -7.00% 0.00% -7.00 ALHC /net-margins <GO>
Revenue Growth (YoY) 3.70% 46.10% -42.40 ALHC /revenue-growth <GO>
Dividend Yield & FCF Payout Safety 0.00% 0.00% 0.00 TIE /dividend-safety <GO>
Altman Z-Score & Debt/Equity 6.97 4.00 +2.97 CSTL /balance-sheet <GO>
Piotroski F-Score Quality 6/9 6/9 0.00 TIE /piotroski-score <GO>
Options Implied Move & Put/Call Skew — — — TIE /options-implied-move <GO>
RSI-14 & 200D SMA Momentum 58.6 36.8 +21.80 CSTL /rsi-technicals <GO>
10Y Yield & FRED Macro Beta — — — TIE /macro-sensitivity <GO>
Forward P/E Multiple — — — TIE /forward-pe <GO>
Enterprise Scale & Market Cap $1.14B $1.52B -$386.2M ALHC /market-cap <GO>
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
FISCAL YEAR CSTL REV ALHC REV CSTL GROSS % ALHC GROSS % CSTL FCF ALHC FCF
FY 2025 $344.2M $3.95B 79.4% — $28.3M $113.1M
FY 2024 $332.1M $2.70B 81.9% — $36.5M -$6.6M
FY 2023 $219.8M $1.80B — — -$5.6M -$59.2M
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
CSTL // BETA —
ALHC // BETA —